Live feed
·
INSIDERFilingvia Quantisnow
Icosavax Inc. logo

Icosavax (ICVX) executive Simpson sold 66,764 shares for $598K at $8.96 under a 10b5-1 plan

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Adam K. Simpson (executive at Icosavax Inc., ICVX) reported that they sold 66,764 shares for $598K at $8.96, and acquired 14,369 shares at $0.84 between Dec 21, 2022 and Dec 23, 2022. After these transactions the filing shows 239,474 shares held directly.

Reporting person
Simpson Adam K.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Dec 21, 2022Open-market sale (S)Common Stock1, 2-66,764$8.96$598K225,105 direct
Dec 23, 2022Exercise or conversion of a derivative (M)Common Stock+14,369$0.84$12.1K239,474 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Dec 23, 2022Exercise or conversion of a derivative (M)Stock Option (Right to Buy)On 14,369 Common Stock3-14,369--33,527 direct

Holdings before and after

  • Common Stock: 291,869 to 239,474 direct
  • Stock Option (Right to Buy): 47,896 to 33,527 direct

Other positions listed

  • Common Stock: 531,576 indirect, By family trust
  • Common Stock: 129,032 indirect, By family trust
  • Common Stock: 129,032 indirect, By family trust

Footnotes from the filing

  1. 1. Represents the sale by the Reporting Person, pursuant to a Rule 10b5-1 trading plan, of a portion of the shares of the Issuer purchased by the Reporting Person via exercise of incentive stock options during 2022. These shares are being sold by the Reporting Person prior to the end of 2022 in order to trigger a disqualifying disposition of such shares and to eliminate the alternative minimum tax that would otherwise arise as a result of the Reporting Person's exercise of such incentive stock options during 2022, with the remainder of the purchased shares continued to be held by the Reporting Person.
  2. 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.54 to $9.41. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. 3. 25% of the shares subject to the option vested on 2/21/2021, and 1/48th of the shares subject to the option vest monthly thereafter.

Transaction codes in this filing

Open-market sale:
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Exercise or conversion of a derivative:
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.

FAQ

What did Simpson report in this ICVX Form 4?

Adam K. Simpson (executive at Icosavax Inc., ICVX) reported that they sold 66,764 shares for $598K at $8.96, and acquired 14,369 shares at $0.84 between Dec 21, 2022 and Dec 23, 2022. After these transactions the filing shows 239,474 shares held directly.

How many ICVX shares does Simpson hold after this filing?

The filing shows 239,474 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

Was this ICVX insider sale made under a 10b5-1 plan?

The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.

What does transaction code S mean on an SEC Form 4?

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Historical context for ICVX

Earlier insider filings at ICVX

Quantisnow market dataNASDAQ
Icosavax Inc. logo
ICVX
Icosavax Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for ICVX

Follow ICVX and get a push notification the moment its next story breaks.

Full ICVX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICVX (Icosavax Inc.) and more on Quantisnow.